PRL3 enhances T cell acute lymphoblastic leukemia growth through suppressing T cell signaling pathways and apoptosis

T cell acute lymphoblastic leukemia (T-ALL) is an aggressive malignancy of thymocytes and is largely driven by the NOTCH/MYC pathway. Yet, additional oncogenic drivers are required for transformation. Here, we identify protein tyrosine phosphatase type 4 A3 (PRL3) as a collaborating oncogenic driver...

Descripción completa

Detalles Bibliográficos
Autores principales: Garcia, E.G., Veloso, A., Oliveira, M.L., Allen, J. R., Loontiens, S., Brunson, D., Do, D., Yan, C., Morris, R., Iyer, S., Garcia, S.P., Iftimia, N., a, Loocke W., Matthijssens, F., McCarthy, K., Barata, J.T., Speleman, F., Taghon, T., Gutierrez, A., Van Vlierberghe, P., Haas, W., Blackburn, J.S., Langenau, D.M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009053/
https://www.ncbi.nlm.nih.gov/pubmed/32606318
http://dx.doi.org/10.1038/s41375-020-0937-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009053/
https://www.ncbi.nlm.nih.gov/pubmed/32606318
http://dx.doi.org/10.1038/s41375-020-0937-3

Ejemplares similares